On April 10, 1991, just five days after New York Mayor David Dinkins proclaimed his unqualified support for testing and marketing of the French abortion pill, RU 486, in the United States, medical authorities in France announced the first confirmed death associated with the drug. Two other women had earlier suffered life-threatening heart attacks and survived.
Sensing the public-relations disaster, proponents quickly announced that the fault was not with RU 486 itself, but rather with the prostaglandin Nalador (sulprostone). The French use RU 486 with the prostaglandin to increase its "effectiveness."
Indeed, no sooner did these tragic events become public than Etienne Emile Baulieu, the prime promoter of the abortifacient, announced that he had successfully conducted tests using not Nalador, but Cytotec, a prostaglandin manufactured by the U.S. company Searle & Co. of Chicago. As reported in the New York Times on April 9, 1991, we were told this prostaglandin...
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?